Showing results (181-190 of 199) with videos related to
Sort By:
Pageof 20
Journal of Virology|March 24, 2017
BST-2 Expression Modulates Small CD4-Mimetic Sensitization of HIV-1-Infected Cells to Antibody-Dependent Cellular CytotoxicityJonathan Richard, Jérémie Prévost, Benjamin von Bredow, et al.Frontiers in Immunology|February 13, 2024
Evolutionary and functional characterization of lagomorph guanylate-binding proteins: a story of gain and loss and shedding light on expression, localization and innate immunity-related functionsLuca Schelle, João Vasco Côrte-Real, Sharmeen Fayyaz, et al.Cell Host & Microbe|June 9, 2019
IFI16 Targets the Transcription Factor Sp1 to Suppress HIV-1 Transcription and Latency ReactivationDominik Hotter, Matteo Bosso, Kasper L Jønsson, et al.Mbio|June 20, 2019
Upregulation of BST-2 by Type I Interferons Reduces the Capacity of Vpu To Protect HIV-1-Infected Cells from NK Cell ResponsesJérémie Prévost, Suzanne Pickering, Mitchell J Mumby, et al.Cell Host & Microbe|December 20, 2014
Nef proteins of epidemic HIV-1 group O strains antagonize human tetherinSilvia F Kluge, Katharina Mack, Shilpa S Iyer, et al.Proceedings of the National Academy of Sciences of the United States of America|April 20, 2021
Structural basis for GTP-induced dimerization and antiviral function of guanylate-binding proteinsWen Cui, Elisabeth Braun, Wei Wang, et al.Cell Reports|May 16, 2019
Guanylate-Binding Proteins 2 and 5 Exert Broad Antiviral Activity by Inhibiting Furin-Mediated Processing of Viral Envelope ProteinsElisabeth Braun, Dominik Hotter, Lennart Koepke, et al.Cell Host & Microbe|November 18, 2009
Tetherin-driven adaptation of Vpu and Nef function and the evolution of pandemic and nonpandemic HIV-1 strainsDaniel Sauter, Michael Schindler, Anke Specht, et al.Science Advances|May 7, 2025
Inhibition of placental trophoblast fusion by guanylate-binding protein 5Veronika Krchlikova, Elisabeth Braun, Johanna Weiss, et al.Cell Reports|May 11, 2021
Systematic functional analysis of SARS-CoV-2 proteins uncovers viral innate immune antagonists and remaining vulnerabilitiesManuel Hayn, Maximilian Hirschenberger, Lennart Koepke, et al.Pageof 20